Market Drivers and Restraints:
The global market for biologics is majorly driven by the availability of wide range of biologics such as vaccines, allergenics, blood, blood components, somatic cells, tissues, gene therapies, living cells used in cell therapy and recombinant therapeutic protein. The increasing number of individuals with chronic and acute diseases, such as cancer, diabetes, anemia and others, that involves biologics in their treatment is inducing demand for biologics or biologic drugs in the global market.
Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/1339
The growing approval of patient-centric and personalized medicines and increasing resistance towards conventional drugs are impacting positively on the expansion of the global biologics market. The increasing inclination towards the adoption of medicines that are derived from natural sources owing to the high rate of side-effects caused by the conventional chemically synthesized drugs is creating traction for biologics in the global market, resulting in the expansion of the global biologics market.
The high success rate in terms of approval of biologic drugs has created a broad pathway of opportunities for the manufacturers, which in turn is fueling the growth of the global biologics market. The increased research and development expenditure by the pharmaceutical companies has led to the introduction of new and efficient biologic drugs in the global market, leading to the expansion of the global biologics market. However, the high capital investment for research and development of biologics, high cost of biologics and development of biosimilars are likely to act as a restraint on the growth of the global biologics market.
Market Segmentation
The Market Research Future report offers a complete segmental analysis of the biologics market based on manufacturing, disease indication, and product.
Based
on product, the global biologics market is segmented into gene therapy,
growth factors, vaccines, interleukins, monoclonal antibody, and
others. Of these, the monoclonal antibody segment will have the largest
share in the market during the forecast period for its increasing use
for enhancing the body’s immunity system.
Based
on disease indication, the biologics market is segmented into diabetes,
cancer, psoriasis/psoriatic arthritis, rheumatoid arthritis, and
others. Of these, the cancer segment dominated the market in 2018, but
rheumatoid arthritis is predicted to dominate the biologics market over
the forecast period for the rapid approval of different drugs by the
regulatory agencies.
Based on manufacturing, the biologics market is segmented into outsourced and in-house. Of these, the outsourced segment will have the maximum share in the market during the forecast period for the presence of several pharmaceutical companies, especially in developing countries.
Regional Analysis:
The global biologics market is geographically segmented into four major regions such as America, Europe, Asia Pacific and the Middle East and Africa. Among these, the Americas is anticipated to dominate the global biologics market owing to the high prevalence of diseases such as cancer and diabetes. The Europe region accounts for the second largest share of the global biologics market owing to the increasing healthcare expenditure and rise in government support for research and development of biologics in this region. The increasing geriatric population and demand for biologic products are driving the expansion of the biologics market in the Asia Pacific region. However, the low penetration of advanced medications and poor healthcare facilities in the underdeveloped regions of the Middle East and Africa are leading to the steady growth of the biologics market in this region.
Key Players
Notable
players profiled in the biologics market report include GlaxoSmithKline
Plc (UK), Eli Lilly and Company (US), Bayer AG (Germany), Sanofi
(France), F. Hoffman-La Roche AG (Switzerland), Novartis AG
(Switzerland), Amgen (US), Pfizer Inc. (US), AstraZeneca (UK), and
AbbVie, Inc. (US). Key players have incorporated specific strategies to
increase their market share, such as acquisitions, expansions, and new
product launches.
Industry News
December 2019: Researchers at the Shenzhen Institutes of Advanced Technology, China, and Duke University, US, have created a platform that will make the biologics production process simpler.
1 Report Prologue
2 Market Introduction
2.1 Introduction 15
2.2 Scope Of The Study 15
2.3 Assumptions & Limitations 15
3 Research Methodology
3.1 Research Process 18
3.2 Primary Research 19
3.3 Secondary Research 20
3.4 Market Size Estimation 21
3.5 Forecast Model 21
4 Market Dynamics
4.1 Introduction 23
4.2 Drivers 23
4.2.1 Increasing Healthcare Expenditure 23
4.2.2 Advancements In Biologics 24
4.2.3 Rising Prevalence Of Chronic And Acute Diseases 24
4.3 Restraints 24
4.3.1 Emergence Of Biosimilars 24
4.3.2 Adverse Effects Of Biologic Drugs 24
4.4 Opportunities 25
4.4.1 Strong Pipeline For Biologic Drugs 25
5 Market Factor Analysis
5.1 Value/Supply Chain Analysis 27
5.1.1 Research & Development 27
5.1.2 Raw Material 27
5.1.3 Manufacturer 27
5.1.4 Distributor 28
5.1.5 Customer 28
5.1.6 Consumer 28
5.2 Porter’s Five Force Analysis 29
5.2.1 Threat From A New Entrant 30
5.2.2 Bargaining Power Of Buyer 30
5.2.3 Bargaining Power Of Supplier 30
5.2.4 Threat From Substitute 31
5.2.5 Rivalry 31
5.3 Investment Opportunity Analysis 32
5.3.1 Investment Risks 32
5.3.2 Market Outlook 32
5.4 Pricing Analysis 32
Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/biologics-market-1339
Related reports link:-
Amyotrophic Lateral Sclerosis Market
Compression Therapy Market
Veterinary Vaccines Market
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
https://marketreports4u.blogspot.com/
NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
0 Comments